Company Overview

Update
Founded:
2003
Founders:
Mark J. Gabrielson, Alexander Klibanov, Robert S. Langer
Headquarters:
Lexington, MA
Funding:
$73.9M
Categories:
Biotechnology
Description:
Pulmatrix develops inhaled therapies for the treatment, prevention and transmission of infectious and progressive respiratory diseases.

Detailed Description

Update

Pulmatrix, Inc., a clinical stage biopharmaceutical company, develops inhaled therapies for the treatment, prevention, and transmission control of infectious and progressive respiratory diseases. It offers inhaled cationic airway lining modulator drugs, which stimulate host defense mechanisms within the airway to treat and prevent influenza, rhinovirus, and chronic pulmonary diseases. The company was founded in 2003 and is based in Lexington, Massachusetts.

Current Team (9)

Update

Past Team (5)

Update

Funding Rounds (5) - $73.9M

Update

Board Members and Advisors (11)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    99 Hayden Avenue

    Suite 390

    Lexington, MA 02421

    USA

Images (1)

Update
  • 561fe7262da97f208ec78e42f06e7ab6